The STI/HIV/Viral Hepatitis Branch of the Disease Control and Environmental Epidemiology Division recently launched a media campaign to help reduce HIV infection in Colorado adults by increasing the use of a medication for pre-exposure prophylaxis (PrEP). The campaign, “Proud to be PrEPPED,” aims to increase awareness and use of Truvada, a daily preventative oral medication. When taken every day, Truvada is more than 92 percent effective in preventing sexually-acquired HIV infection.
Over the past five years, between 325 and 400 new people have been diagnosed with HIV each year in Colorado, and about 12,300 Coloradans ages 13 and up currently are living with HIV. PrEP, in combination with virus-suppressing medicines for people who have HIV and other risk-reduction options, can limit the spread of the virus.
The population prioritized for phase one of the campaign includes men who have sex with men, transgender people, partners of those living with HIV and others at risk for getting HIV. Health care providers who can prescribe PrEP will be prioritized in phase two of the project.
The campaign, developed in conjunction with state-designated marketing firm Amelie Company, includes a website: ProudToBePrePPED.com, a phone info-line, social media sites (Facebook, Vimeo and YouTube), website and print advertising, and targeted, paid editorial content.
To find out how to get PrEP, call, 1-844-367-7075. Please share this information with your partners.